Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel

✍ Scribed by Minetta C. Liu; George D. Demetri; Donald A. Berry; Larry Norton; Gloria Broadwater; Nicholas J. Robert; David Duggan; Daniel F. Hayes; I. Craig Henderson; Alan Lyss; Judith Hopkins; Peter A. Kaufman; P. Kelly Marcom; Jerry Younger; Nancy Lin; Katherine Tkaczuk; Eric P. Winer; Clifford A. Hudis

• Book ID: 116395177
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 165 KB
• Volume: 34
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/j.ctrv.2007.11.004